Upexi, Inc. Overview
Pro stress-test →Upexi engages in the development, manufacture, and distribution of consumer products, offering nail grinders and pet supplements under the LuckyTail brand, energy solutions under the PRAX brand, functional mushrooms under the Cure Mushrooms brand, cannabinoid products under the Moonwlkr brand, and gummies under the Gumi Labs brand. The company also focuses on cryptocurrency industry and management of cash assets, positioning itself at the intersection of consumer brands and digital asset treasury management.
Strategic Profile
Pro stress-test →Upexi is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while utilizing in-house SaaS programmatic ad technology for lower customer acquisition costs. The company is a Solana-focused treasury company, recently announcing aggressive Solana accumulation strategies alongside its core consumer products business.
Competitive Landscape
Pro stress-test →Upexi sells products through direct-to-consumer networks, wholesale partnerships, and third-party platforms, competing in fragmented pet care, supplements, and functional food markets. Direct competitors include established D2C consumer brands (like Chewy for pets), supplement aggregators, and emerging Solana-focused treasury companies in the crypto ecosystem.
Industry Context
Upexi, Inc. operates in Consumer Products / Cryptocurrency Treasury Management.
Key facts
Founded: 2018 · Headquarters: Tampa, Florida · Revenue: $8.1M (Q2 2026, annualized ~$32M) · Market cap: $146.3M